Guggenheim Starts Sagent Pharmaceuticals (SGNT) at Neutral
Tweet Send to a Friend
Guggenheim initiates coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE